Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
An Enquiry
Product Reset all filters
01 1Vanflyta
Quizartinib
Daiichi Sankyo
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 24
2023 Revenue in Millions : 9
Growth (%) : 169
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF